Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Leigh Murphy

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Breast Neoplasms

Chemicals & Drugs

Anatomy

Cultured Tumor Cells

Physiology

Procedures

Reverse Transcriptase Polymerase Chain Reaction

Concepts & Ideas

Molecular Sequence Data

Phenomena

Western Blotting

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
52
Watson, Peter
41
Leygue, Etienne
38
Dotzlaw, Helmut
21
Murphy, Liam
13
Snell, Linda
12
Davie, James
11
Emberley, Ethan
9
Coutts, AS
9
Niu, Yulian
9
SKLIRIS, GEORGIOS
9
Shiu, Robert
9
Troup, Sandra
5
Ung, Kanyarat
5
Peng, Baocheng
5
Adeyinka, Adewale

Sign-in to see all Coauthors

Publications

TOP 3
Skliris George P; Rowan Brian G; Al-Dhaheri Mariam; Williams Christopher; Troup Sandy; Begic Sanela; Parisien Michelle; Watson Peter H; Murphy Leigh C
Immunohistochemical validation of multiple phospho-specific epitopes for estrogen receptor alpha (ERalpha) in tissue microarrays of ERalpha positive human breast carcinomas.
Weitsman Gregory E; Weebadda Wineeta; Ung Kanyarat; Murphy Leigh C
Reactive oxygen species induce phosphorylation of serine 118 and 167 on estrogen receptor alpha.
Cooper Charlton; Guo Jimin; Yan Yi; Chooniedass-Kothari Shilpa; Hube Florent; Hamedani Mohammad K; Murphy Leigh C; Myal Yvonne; Leygue Etienne
Increasing the relative expression of endogenous non-coding Steroid Receptor RNA Activator (SRA) in human breast cancer cells using modified oligonucleotides.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Leigh Murphy (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Skliris George P; Rowan Brian G; Al-Dhaheri Mariam; Williams Christopher; Troup Sandy; Begic Sanela; Parisien Michelle; Watson Peter H; Murphy Leigh C
Immunohistochemical validation of multiple phospho-specific epitopes for estrogen receptor alpha (ERalpha) in tissue microarrays of ERalpha positive human breast carcinomas.
Breast cancer research and treatment 2009;118(3):443-53.
2009: Weitsman Gregory E; Weebadda Wineeta; Ung Kanyarat; Murphy Leigh C
Reactive oxygen species induce phosphorylation of serine 118 and 167 on estrogen receptor alpha.
Breast cancer research and treatment 2009;118(2):269-79.
2009: Cooper Charlton; Guo Jimin; Yan Yi; Chooniedass-Kothari Shilpa; Hube Florent; Hamedani Mohammad K; Murphy Leigh C; Myal Yvonne; Leygue Etienne
Increasing the relative expression of endogenous non-coding Steroid Receptor RNA Activator (SRA) in human breast cancer cells using modified oligonucleotides.
Nucleic acids research 2009;37(13):4518-31.
2009: Blanchard Anne A; Skliris George P; Watson Peter H; Murphy Leigh C; Penner Carla; Tomes Ladislav; Young Tamara L; Leygue Etienne; Myal Yvonne
Claudins 1, 3, and 4 protein expression in ER negative breast cancer correlates with markers of the basal phenotype.
Virchows Archiv : an international journal of pathology 2009;454(6):647-56.
2009: Murphy Leigh C; Skliris Georgios P; Rowan Brian G; Al-Dhaheri Mariam; Williams Christopher; Penner Carla; Troup Sandy; Begic Sanela; Parisien Michelle; Watson Peter H
The relevance of phosphorylated forms of estrogen receptor in human breast cancer in vivo.
The Journal of steroid biochemistry and molecular biology 2009;114(1-2):90-5.
2008: Skliris George P; Leygue Etienne; Watson Peter H; Murphy Leigh C
Estrogen receptor alpha negative breast cancer patients: estrogen receptor beta as a therapeutic target.
The Journal of steroid biochemistry and molecular biology 2008;109(1-2):1-10.
2008: Skliris G P; Hubé F; Gheorghiu I; Mutawe M M; Penner C; Watson P H; Murphy L C; Leygue E; Myal Y
Expression of small breast epithelial mucin (SBEM) protein in tissue microarrays (TMAs) of primary invasive breast cancers.
Histopathology 2008;52(3):355-69.
2007: Cherlet Tracy; Murphy Leigh C
Estrogen receptors inhibit Smad3 transcriptional activity through Ap-1 transcription factors.
Molecular and cellular biochemistry 2007;306(1-2):33-42.
2007: Mandal Soma; Curtis Linda; Pind Molly; Murphy Leigh C; Watson Peter H
S100A7 (psoriasin) influences immune response genes in human breast cancer.
Experimental cell research 2007;313(14):3016-25.
2007: Skliris George P; Lewis Anthony; Emberley Ethan; Peng Baocheng; Weebadda Wineeta K; Kemp Angela; Davie James R; Shiu Robert P C; Watson Peter H; Murphy Leigh C
Estrogen receptor-beta regulates psoriasin (S100A7) in human breast cancer.
Breast cancer research and treatment 2007;104(1):75-85.
2006: Murphy Leigh C; Weitsman G E; Skliris G P; Teh E M; Li Lin; Peng B; Davie J R; Ung K; Niu Y-L; Troup S; Tomes L; Watson P H
Potential role of estrogen receptor alpha (ERalpha) phosphorylated at Serine118 in human breast cancer in vivo.
The Journal of steroid biochemistry and molecular biology 2006;102(1-5):139-46.
2006: Weitsman Gregory E; Skliris George; Ung Kanyarat; Peng Baocheng; Younes Mamoun; Watson Peter H; Murphy Leigh C
Assessment of multiple different estrogen receptor-beta antibodies for their ability to immunoprecipitate under chromatin immunoprecipitation conditions.
Breast cancer research and treatment 2006;100(1):23-31.
2006: Weitsman Gregory E; Li Lin; Skliris George P; Davie James R; Ung Kanyarat; Niu Yulian; Curtis-Snell Linda; Tomes Ladislav; Watson Peter H; Murphy Leigh C
Estrogen receptor-alpha phosphorylated at Ser118 is present at the promoters of estrogen-regulated genes and is not altered due to HER-2 overexpression.
Cancer research 2006;66(20):10162-70.
2006: Skliris G P; Leygue E; Curtis-Snell L; Watson P H; Murphy L C
Expression of oestrogen receptor-beta in oestrogen receptor-alpha negative human breast tumours.
British journal of cancer 2006;95(5):616-26.
2006: Murphy Leigh C; Watson Peter H
Is oestrogen receptor-beta a predictor of endocrine therapy responsiveness in human breast cancer?
Endocrine-related cancer 2006;13(2):327-34.
2006: Mishra Suresh; Murphy Leigh C; Murphy Liam J
The Prohibitins: emerging roles in diverse functions.
Journal of cellular and molecular medicine 2006;10(2):353-63.
2006: Johnston James B; Navaratnam Sri; Pitz Marshall W; Maniate Jerry M; Wiechec Emilia; Baust Heinrich; Gingerich Joel; Skliris Georgios P; Murphy Leigh C; Los Marek
Targeting the EGFR pathway for cancer therapy.
Current medicinal chemistry 2006;13(29):3483-92.
2005: Cammarata Patrick R; Flynn James; Gottipati Srinivas; Chu Shaoyou; Dimitrijevich Slobadan; Younes Mamoun; Skliris George; Murphy Leigh C
Differential expression and comparative subcellular localization of estrogen receptor beta isoforms in virally transformed and normal cultured human lens epithelial cells.
Experimental eye research 2005;81(2):165-75.
2005: Emberley Ethan D; Niu Yulian; Curtis Linda; Troup Sandra; Mandal Sanat K; Myers Jeffery N; Gibson Spencer B; Murphy Leigh C; Watson Peter H
The S100A7-c-Jun activation domain binding protein 1 pathway enhances prosurvival pathways in breast cancer.
Cancer research 2005;65(13):5696-702.
2005: Mishra Suresh; Murphy Leigh C; Nyomba B L Gregoire; Murphy Liam J
Prohibitin: a potential target for new therapeutics.
Trends in molecular medicine 2005;11(4):192-7.
2005: Murphy L C; Peng B; Lewis A; Davie J R; Leygue E; Kemp A; Ung K; Vendetti M; Shiu R
Inducible upregulation of oestrogen receptor-beta1 affects oestrogen and tamoxifen responsiveness in MCF7 human breast cancer cells.
Journal of molecular endocrinology 2005;34(2):553-66.
2005: Webb Meghan; Emberley Ethan D; Lizardo Michael; Alowami Salem; Qing Gefei; Alfia'ar Abdullah; Snell-Curtis Linda J; Niu Yulian; Civetta Alberto; Myal Yvonne; Shiu Robert; Murphy Leigh C; Watson Peter H
Expression analysis of the mouse S100A7/psoriasin gene in skin inflammation and mammary tumorigenesis.
BMC cancer 2005;5():17.
2004: Cooper Charlton; Liu Guang-Yu; Niu Yu-Lian; Santos Sylvia; Murphy Leigh C; Watson Peter H
Intermittent hypoxia induces proteasome-dependent down-regulation of estrogen receptor alpha in human breast carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(24):8720-7.
2004: Murphy Leigh C; Niu Yulian; Snell Linda; Watson Peter
Phospho-serine-118 estrogen receptor-alpha expression is associated with better disease outcome in women treated with tamoxifen.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(17):5902-6.
2004: Emberley Ethan D; Murphy Leigh C; Watson Peter H
S100 proteins and their influence on pro-survival pathways in cancer.
Biochemistry and cell biology = Biochimie et biologie cellulaire 2004;82(4):508-15.
2004: Emberley Ethan D; Alowami Salem; Snell Linda; Murphy Leigh C; Watson Peter H
S100A7 (psoriasin) expression is associated with aggressive features and alteration of Jab1 in ductal carcinoma in situ of the breast.
Breast cancer research : BCR 2004;6(4):R308-15.
2004: Emberley Ethan D; Murphy Leigh C; Watson Peter H
S100A7 and the progression of breast cancer.
Breast cancer research : BCR 2004;6(4):153-9.
2003: Guan Xiao-feng; Hamedani Mohammad K; Adeyinka Adewale; Walker Christina; Kemp Angela; Murphy Leigh C; Watson Peter H; Leygue Etienne
Relationship between mammaglobin expression and estrogen receptor status in breast tumors.
Endocrine 2003;21(3):245-50.
2003: Emberley Ethan D; Niu Yulian; Njue Catherine; Kliewer Erich V; Murphy Leigh C; Watson Peter H
Psoriasin (S100A7) expression is associated with poor outcome in estrogen receptor-negative invasive breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(7):2627-31.
2003: Emberley Ethan D; Niu Yulian; Leygue Etienne; Tomes Ladislav; Gietz R Daniel; Murphy Leigh C; Watson Peter H
Psoriasin interacts with Jab1 and influences breast cancer progression.
Cancer research 2003;63(8):1954-61.
2003: Peng B; Lu B; Leygue E; Murphy L C
Putative functional characteristics of human estrogen receptor-beta isoforms.
Journal of molecular endocrinology 2003;30(1):13-29.
2003: Emberley Ethan; Huang Guo-Jian; Hamedani Mohammad K; Czosnek Anna; Ali Djiae; Grolla Allen; Lu Biao; Watson Peter H; Murphy Leigh C; Leygue Etienne
Identification of new human coding steroid receptor RNA activator isoforms.
Biochemical and biophysical research communications 2003;301(2):509-15.
2003: Troup Sandra; Njue Catherine; Kliewer Erich V; Parisien Michelle; Roskelley Cal; Chakravarti Shukti; Roughley Peter J; Murphy Leigh C; Watson Peter H
Reduced expression of the small leucine-rich proteoglycans, lumican, and decorin is associated with poor outcome in node-negative invasive breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(1):207-14.
2002: Adeyinka Adewale; Emberley Ethan; Niu Yulian; Snell Linda; Murphy Leigh C; Sowter Heidi; Wykoff Charles C; Harris Adrian L; Watson Peter H
Analysis of gene expression in ductal carcinoma in situ of the breast.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(12):3788-95.
2002: Murphy L C; Leygue E; Niu Y; Snell L; Ho S-M; Watson P H
Relationship of coregulator and oestrogen receptor isoform expression to de novo tamoxifen resistance in human breast cancer.
British journal of cancer 2002;87(12):1411-6.
2002: Emberley Ethan D; Gietz R Daniel; Campbell J Darren; HayGlass Kent T; Murphy Leigh C; Watson Peter H
RanBPM interacts with psoriasin in vitro and their expression correlates with specific clinical features in vivo in breast cancer.
BMC cancer 2002;2():28.
2002: Adeyinka Adewale; Nui Yulian; Cherlet Tracy; Snell Linda; Watson Peter H; Murphy Leigh C
Activated mitogen-activated protein kinase expression during human breast tumorigenesis and breast cancer progression.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(6):1747-53.
2002: Miksicek Richard J; Myal Yvonne; Watson Peter H; Walker Christina; Murphy Leigh C; Leygue Etienne
Identification of a novel breast- and salivary gland-specific, mucin-like gene strongly expressed in normal and tumor human mammary epithelium.
Cancer research 2002;62(10):2736-40.
2002: Murphy L C; Watson P
Steroid receptors in human breast tumorigenesis and breast cancer progression.
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2002;56(2):65-77.
2000: Murphy L C; Simon S L; Parkes A; Leygue E; Dotzlaw H; Snell L; Troup S; Adeyinka A; Watson P H
Altered expression of estrogen receptor coregulators during human breast tumorigenesis.
Cancer research 2000;60(22):6266-71.
2000: Leygue E; Snell L; Dotzlaw H; Troup S; Hiller-Hitchcock T; Murphy L C; Roughley P J; Watson P H
Lumican and decorin are differentially expressed in human breast carcinoma.
The Journal of pathology 2000;192(3):313-20.
2000: Lu B; Leygue E; Dotzlaw H; Murphy L J; Murphy L C
Functional characteristics of a novel murine estrogen receptor-beta isoform, estrogen receptor-beta 2.
Journal of molecular endocrinology 2000;25(2):229-42.
2000: Simon S L; Parkes A; Leygue E; Dotzlaw H; Snell L; Troup S; Adeyinka A; Watson P H; Murphy L C
Expression of a repressor of estrogen receptor activity in human breast tumors: relationship to some known prognostic markers.
Cancer research 2000;60(11):2796-9.
2000: Leygue E; Dotzlaw H; Watson P H; Murphy L C
Altered expression of estrogen receptor-alpha variant messenger RNAs between adjacent normal breast and breast tumor tissues.
Breast cancer research : BCR 2000;2(1):64-72.
1999: Huang A; Leygue E; Dotzlaw H; Murphy L C; Watson P H
Influence of estrogen receptor variants on the determination of ER status in human breast cancer.
Breast cancer research and treatment 1999;58(3):219-25.
1999: Lu B; Dotzlaw H; Leygue E; Murphy L J; Watson P H; Murphy L C
Estrogen receptor-alpha mRNA variants in murine and human tissues.
Molecular and cellular endocrinology 1999;158(1-2):153-61.
1999: Coutts A S; Leygue E; Murphy L C
Variant estrogen receptor-alpha messenger RNA expression in hormone-independent human breast cancer cells.
Journal of molecular endocrinology 1999;23(3):325-36.
1999: Al-Haddad S; Zhang Z; Leygue E; Snell L; Huang A; Niu Y; Hiller-Hitchcock T; Hole K; Murphy L C; Watson P H
Psoriasin (S100A7) expression and invasive breast cancer.
The American journal of pathology 1999;155(6):2057-66.
1999: Leygue E; Dotzlaw H; Watson P H; Murphy L C
Expression of the steroid receptor RNA activator in human breast tumors.
Cancer research 1999;59(17):4190-3.
1999: Leygue E; Snell L; Dotzlaw H; Hole K; Troup S; Hiller-Hitchcock T; Murphy L C; Watson P H
Mammaglobin, a potential marker of breast cancer nodal metastasis.
The Journal of pathology 1999;189(1):28-33.
1999: Dotzlaw H; Leygue E; Watson P; Murphy L C
The human orphan receptor PXR messenger RNA is expressed in both normal and neoplastic breast tissue.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(8):2103-7.
1999: Leygue E; Dotzlaw H; Watson P H; Murphy L C
Altered expression of exon 6 deleted progesterone receptor variant mRNA between normal human breast and breast tumour tissues.
British journal of cancer 1999;80(3-4):379-82.
1999: Leygue E; Dotzlaw H; Watson P H; Murphy L C
Expression of estrogen receptor beta1, beta2, and beta5 messenger RNAs in human breast tissue.
Cancer research 1999;59(6):1175-9.
1999: Leygue E; Hall R E; Dotzlaw H; Watson P H; Murphy L C
Oestrogen receptor-alpha variant mRNA expression in primary human breast tumours and matched lymph node metastases.
British journal of cancer 1999;79(5-6):978-83.
1999: Dotzlaw H; Leygue E; Watson P H; Murphy L C
Estrogen receptor-beta messenger RNA expression in human breast tumor biopsies: relationship to steroid receptor status and regulation by progestins.
Cancer research 1999;59(3):529-32.
1998: Spencer V A; Coutts A S; Samuel S K; Murphy L C; Davie J R
Estrogen regulates the association of intermediate filament proteins with nuclear DNA in human breast cancer cells.
The Journal of biological chemistry 1998;273(44):29093-7.
1998: Leygue E; Dotzlaw H; Lu B; Glor C; Watson P H; Murphy L C
Estrogen receptor beta: mine is longer than yours?
The Journal of clinical endocrinology and metabolism 1998;83(10):3754-5.
1998: Coutts A S; Murphy L C
Elevated mitogen-activated protein kinase activity in estrogen-nonresponsive human breast cancer cells.
Cancer research 1998;58(18):4071-4.
1998: Leygue E; Dotzlaw H; Watson P H; Murphy L C
Altered estrogen receptor alpha and beta messenger RNA expression during human breast tumorigenesis.
Cancer research 1998;58(15):3197-201.
1998: Watson P H; Leygue E R; Murphy L C
Psoriasin (S100A7).
The international journal of biochemistry & cell biology 1998;30(5):567-71.
1998: Murphy L C; Dotzlaw H; Leygue E; Coutts A; Watson P
The pathophysiological role of estrogen receptor variants in human breast cancer.
The Journal of steroid biochemistry and molecular biology 1998;65(1-6):175-80.
1998: Leygue E; Snell L; Dotzlaw H; Hole K; Hiller-Hitchcock T; Roughley P J; Watson P H; Murphy L C
Expression of lumican in human breast carcinoma.
Cancer research 1998;58(7):1348-52.
1998: Lu B; Leygue E; Dotzlaw H; Murphy L J; Murphy L C; Watson P H
Estrogen receptor-beta mRNA variants in human and murine tissues.
Molecular and cellular endocrinology 1998;138(1-2):199-203.
1997: Holth L T; Sun J M; Coutts A S; Murphy L C; Davie J R
Estrogen receptor diminishes DNA-binding activities of chicken GATA-1 and CACCC-binding proteins.
DNA and cell biology 1997;16(12):1477-82.
1997: Murphy L C; Dotzlaw H; Leygue E; Douglas D; Coutts A; Watson P H
Estrogen receptor variants and mutations.
The Journal of steroid biochemistry and molecular biology 1997;62(5-6):363-72.
1997: Dotzlaw H; Leygue E; Watson P H; Murphy L C
Expression of estrogen receptor-beta in human breast tumors.
The Journal of clinical endocrinology and metabolism 1997;82(7):2371-4.
1997: Murphy L C; Leygue E; Dotzlaw H; Douglas D; Coutts A; Watson P H
Oestrogen receptor variants and mutations in human breast cancer.
Annals of medicine 1997;29(3):221-34.
1997: Wang M; Dotzlaw H; Fuqua S A; Murphy L C
A point mutation in the human estrogen receptor gene is associated with the expression of an abnormal estrogen receptor mRNA containing a 69 novel nucleotide insertion.
Breast cancer research and treatment 1997;44(2):145-51.
1997: Huang A; Leygue E R; Snell L; Murphy L C; Watson P H
Expression of estrogen receptor variant messenger RNAs and determination of estrogen receptor status in human breast cancer.
The American journal of pathology 1997;150(5):1827-33.
1996: Coutts A S; Davie J R; Dotzlaw H; Murphy L C
Estrogen regulation of nuclear matrix-intermediate filament proteins in human breast cancer cells.
Journal of cellular biochemistry 1996;63(2):174-84.
1996: Leygue E; Dotzlaw H; Watson P H; Murphy L C
Identification of novel exon-deleted progesterone receptor variant mRNAs in human breast tissue.
Biochemical and biophysical research communications 1996;228(1):63-8.
1996: Leygue E; Snell L; Hiller T; Dotzlaw H; Hole K; Murphy L C; Watson P H
Differential expression of psoriasin messenger RNA between in situ and invasive human breast carcinoma.
Cancer research 1996;56(20):4606-9.
1996: Leygue E; Huang A; Murphy L C; Watson P H
Prevalence of estrogen receptor variant messenger RNAs in human breast cancer.
Cancer research 1996;56(19):4324-7.
1996: Murphy L C; Huzel N; Davie J R
Novel DNase I hypersensitive sites in the 3'-flanking region of the human c-myc gene.
DNA and cell biology 1996;15(7):543-8.
1996: Murphy L C; Wang M; Coutt A; Dotzlaw H
Novel mutations in the estrogen receptor messenger RNA in human breast cancers.
The Journal of clinical endocrinology and metabolism 1996;81(4):1420-7.
1996: Miller T L; Jin Y; Sun J M; Coutts A S; Murphy L C; Davie J R
Analysis of human breast cancer nuclear proteins binding to the promoter elements of the c-myc gene.
Journal of cellular biochemistry 1996;60(4):560-71.
1995: Murphy L C; Hilsenbeck S G; Dotzlaw H; Fuqua S A
Relationship of clone 4 estrogen receptor variant messenger RNA expression to some known prognostic variables in human breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1995;1(2):155-9.
1994: Davie J R; Murphy L C
Inhibition of transcription selectively reduces the level of ubiquitinated histone H2B in chromatin.
Biochemical and biophysical research communications 1994;203(1):344-50.
1994: Gong Y; Murphy L C; Murphy L J
Hormonal regulation of proliferation and transforming growth factors gene expression in human endometrial adenocarcinoma xenografts.
The Journal of steroid biochemistry and molecular biology 1994;50(1-2):13-9.
1994: Murphy L C; Alkhalaf M; Dotzlaw H; Coutts A; Haddad-Alkhalaf B
Regulation of gene expression in T-47D human breast cancer cells by progestins and antiprogestins.
Human reproduction (Oxford, England) 1994;9 Suppl 1():174-80.
1994: Murphy L C
Antiestrogen action and growth factor regulation.
Breast cancer research and treatment 1994;31(1):61-71.
1994: Coutts A; Murphy L J; Murphy L C
Expression of insulin-like growth factor binding proteins by T-47D human breast cancer cells: regulation by progestins and antiestrogens.
Breast cancer research and treatment 1994;32(2):153-64.
1993: Alkhalaf M; Murphy L J; Murphy L C
Enhanced c-jun activity alters responsiveness to medroxyprogesterone acetate in Ishikawa human endometrial carcinoma cells.
Molecular endocrinology (Baltimore, Md.) 1993;7(12):1634-41.
1993: Miller T L; Huzel N J; Davie J R; Murphy L C
C-myc gene chromatin of estrogen receptor positive and negative breast cancer cells.
Molecular and cellular endocrinology 1993;91(1-2):83-9.
1993: Murphy L C; Dotzlaw H; Hamerton J; Schwarz J
Investigation of the origin of variant, truncated estrogen receptor-like mRNAs identified in some human breast cancer biopsy samples.
Breast cancer research and treatment 1993;26(2):149-61.
1992: Gong Y; Ballejo G; Alkhalaf B; Molnar P; Murphy L C; Murphy L J
Phorbol esters differentially regulate the expression of insulin-like growth factor-binding proteins in endometrial carcinoma cells.
Endocrinology 1992;131(6):2747-54.
1992: Gong Y; Alkhalaf B; Murphy L J; Murphy L C
Differential effects of phorbol esters on proliferation and calcyclin expression in human endometrial carcinoma cells.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1992;3(11):847-53.
1992: Alkhalaf M; Murphy L C
Regulation of c-jun and jun-B by progestins in T-47D human breast cancer cells.
Molecular endocrinology (Baltimore, Md.) 1992;6(10):1625-33.
1992: Murphy L C; Dotzlaw H; Alkhalaf M; Coutts A; Miller T; Wong M S; Gong Y; Murphy L J
Mechanisms of growth inhibition by antiestrogens and progestins in human breast and endometrial cancer cells.
The Journal of steroid biochemistry and molecular biology 1992;43(1-3):117-21.
1992: Dotzlaw H; Alkhalaf M; Murphy L C
Characterization of estrogen receptor variant mRNAs from human breast cancers.
Molecular endocrinology (Baltimore, Md.) 1992;6(5):773-85.
1992: Gong Y; Ballejo G; Murphy L C; Murphy L J
Differential effects of estrogen and antiestrogen on transforming growth factor gene expression in endometrial adenocarcinoma cells.
Cancer research 1992;52(7):1704-9.
1992: Murphy L J; Gong Y; Murphy L C
Regulation of transforming growth factor gene expression in human endometrial adenocarcinoma cells.
The Journal of steroid biochemistry and molecular biology 1992;41(3-8):309-14.
1991: Penner C G; Murphy L C; Huzel N J; Yamada E W
Antigenic reactivity of ribosomal protein S6 and the calcium-binding ATPase inhibitor protein of mammalian mitochondria.
Molecular and cellular biochemistry 1991;108(1):57-66.
1991: Gong Y; Anzai Y; Murphy L C; Ballejo G; Holinka C F; Gurpide E; Murphy L J
Transforming growth factor gene expression in human endometrial adenocarcinoma cells: regulation by progestins.
Cancer research 1991;51(20):5476-81.
1991: Wong M S; Murphy L C
Differential regulation of c-myc by progestins and antiestrogens in T-47D human breast cancer cells.
The Journal of steroid biochemistry and molecular biology 1991;39(1):39-44.
1991: Murphy L C; Dotzlaw H; Wong M S; Miller T; Murphy L J
Mechanisms involved in the evolution of progestin resistance in human breast cancer cells.
Cancer research 1991;51(8):2051-7.
1991: Murphy L J; Gong Y; Murphy L C; Bhavnani B
Growth factors in normal and malignant uterine tissue.
Annals of the New York Academy of Sciences 1991;622():383-91.
1990: Murphy L C
Estrogen receptor variants in human breast cancer.
Molecular and cellular endocrinology 1990;74(2):C83-6.
1990: Murphy L C; Dotzlaw H; Wong M S; Miller T; Mrockowski B; Gong Y; Murphy L J
Epidermal growth factor: receptor and ligand expression in human breast cancer.
Seminars in cancer biology 1990;1(5):305-15.
1990: Dotzlaw H; Miller T; Karvelas J; Murphy L C
Epidermal growth factor gene expression in human breast cancer biopsy samples: relationship to estrogen and progesterone receptor gene expression.
Cancer research 1990;50(14):4204-8.
1990: Davie J R; Murphy L C
Level of ubiquitinated histone H2B in chromatin is coupled to ongoing transcription.
Biochemistry 1990;29(20):4752-7.
1989: Murphy L C; Dotzlaw H
Variant estrogen receptor mRNA species detected in human breast cancer biopsy samples.
Molecular endocrinology (Baltimore, Md.) 1989;3(4):687-93.
1989: Murphy L C; Dotzlaw H
Regulation of transforming growth factor alpha and transforming growth factor beta messenger ribonucleic acid abundance in T-47D, human breast cancer cells.
Molecular endocrinology (Baltimore, Md.) 1989;3(4):611-7.
1989: Murphy L C; Dotzlaw H
Endogenous growth factor expression in T-47D, human breast cancer cells, associated with reduced sensitivity to antiproliferative effects of progestins and antiestrogens.
Cancer research 1989;49(3):599-604.
1988: Murphy L C; Murphy L J; Dubik D; Bell G I; Shiu R P
Epidermal growth factor gene expression in human breast cancer cells: regulation of expression by progestins.
Cancer research 1988;48(16):4555-60.
1988: Murphy L C; Murphy L J; Tsuyuki D; Duckworth M L; Shiu R P
Cloning and characterization of a cDNA encoding a highly conserved, putative calcium binding protein, identified by an anti-prolactin receptor antiserum.
The Journal of biological chemistry 1988;263(5):2397-401.
1988: Murphy L C; Murphy L J; Shiu R P
Progestin regulation of EGF-receptor mRNA accumulation in T-47D human breast cancer cells.
Biochemical and biophysical research communications 1988;150(1):192-6.
1988: Shiu R P; Murphy L C; Myal Y; Dembinski T C; Tsuyuki D; Iwasiow B M
Actions of pituitary prolactin and insulin-like growth factor II in human breast cancer.
Cancer treatment and research 1988;40():167-83.
1987: Murphy L C; Tsuyuki D; Myal Y; Shiu R P
Isolation and sequencing of a cDNA clone for a prolactin-inducible protein (PIP). Regulation of PIP gene expression in the human breast cancer cell line, T-47D.
The Journal of biological chemistry 1987;262(31):15236-41.
1987: Murphy L J; Murphy L C; Friesen H G
Estrogen induces insulin-like growth factor-I expression in the rat uterus.
Molecular endocrinology (Baltimore, Md.) 1987;1(7):445-50.
1987: Shiu R P; Murphy L C; Tsuyuki D; Myal Y; Lee-Wing M; Iwasiow B
Biological actions of prolactin in human breast cancer.
Recent progress in hormone research 1987;43():277-303.
1987: Murphy L J; Murphy L C; Friesen H G
A role for the insulin-like growth factors as estromedins in the rat uterus.
Transactions of the Association of American Physicians 1987;100():204-14.

Sign-in to see more